JC virus intranuclear inclusions associated with PML-NBs: Analysis by electron microscopy and structured illumination microscopy

American Journal of Pathology

Volumn 180, Issue 3, 2012, Pages 1095-1106

  Shishido Hara, Yukiko ^a   Ichinose, Shizuko ^b   Uchihara, Toshiki ^c  

^a KYORIN UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL ULTRASTRUCTURE; CISTRON; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEGRADATION; ELECTRON MICROSCOPY; EXPRESSION VECTOR; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; JC VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA NUCLEAR BODY; PROTEIN EXPRESSION; VIRUS INCLUSION; VIRUS LIKE AGENT; VIRUS MORPHOLOGY;

CAPSID PROTEINS; CELLS, CULTURED; HUMANS; INTRANUCLEAR INCLUSION BODIES; JC VIRUS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MICROSCOPY; MICROSCOPY, ELECTRON; TRANSFECTION; VIRION;

EID: 84857201350     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.11.036     Document Type: Article

References (57)

1. K.R. Carson, D. Focosi, E.O. Major, M. Petrini, E.A. Richey, D.P. West, C.L. Bennett Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project Lancet Oncol 10 2009 816 824
2. B.K. Kleinschmidt-DeMasters, K.L. Tyler Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis N Engl J Med 353 2005 369 374
3. A. Langer-Gould, S.W. Atlas, A.J. Green, A.W. Bollen, D. Pelletier Progressive multifocal leukoencephalopathy in a patient treated with natalizumab N Engl J Med 353 2005 375 381
4. G. Van Assche, M. Van Ranst, R. Sciot, B. Dubois, S. Vermeire, M. Noman, J. Verbeeck, K. Geboes, W. Robberecht, P. Rutgeerts Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N Engl J Med 353 2005 362 368
5. T.A. Yousry, E.O. Major, C. Ryschkewitsch, G. Fahle, S. Fischer, J. Hou, B. Curfman, K. Miszkiel, N. Mueller-Lenke, E. Sanchez, F. Barkhof, E.W. Radue, H.R. Jger, D.B. Clifford Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy N Engl J Med 354 2006 924 933
6. Y. Shishido-Hara Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease Acta Neuropathol 120 2010 403 417
7. Y. Shishido-Hara, K. Higuchi, S. Ohara, C. Duyckaerts, J.J. Hauw, T. Uchihara Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy J Neuropathol Exp Neurol 67 2008 299 308
8. Y. Shishido-Hara, Y. Hara, T. Larson, K. Yasui, K. Nagashima, G.L. Stoner Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly J Virol 74 2000 1840 1853
9. Y. Shishido-Hara, S. Ichinose, K. Higuchi, Y. Hara, K. Yasui Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions J Virol 78 2004 9890 9903
10. M. Mzl, I. Tariska Morphological demonstration of the first phase of polyomavirus replication in oligodendroglia cells of human brain in progressive multifocal leukoencephalopathy (PML) Acta Neuropathol 49 1980 133 143
11. V. Lallemand-Breitenbach, H. de Th PML nuclear bodies Cold Spring Harb Perspect Biol 2 2010 a000661
12. M. Lang, T. Jegou, I. Chung, K. Richter, S. Mnch, A. Udvarhelyi, C. Cremer, P. Hemmerich, J. Engelhardt, S.W. Hell, K. Rippe Three-dimensional organization of promyelocytic leukemia nuclear bodies J Cell Sci 123 2010 392 400
13. B. Terris, V. Baldin, S. Dubois, C. Degott, J.F. Flejou, D. Henin, A. Dejean PML nuclear bodies are general targets for inflammation and cell proliferation Cancer Res 55 1995 1590 1597
14. G. Dellaire, R.W. Ching, H. Dehghani, Y. Ren, D.P. Bazett-Jones The number of PML nuclear bodies increases in early S phase by a fission mechanism J Cell Sci 119 2006 1026 1033
15. G. Dellaire, C.H. Eskiw, H. Dehghani, R.W. Ching, D.P. Bazett-Jones Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1 J Cell Sci 119 2006 1034 1042
16. Y.C. Chen, C. Kappel, J. Beaudouin, R. Eils, D.L. Spector Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis Mol Biol Cell 19 2008 3147 3162
17. R. Bernardi, P.P. Pandolfi Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies Nat Rev Mol Cell Biol 8 2007 1006 1016
18. R. Bernardi, A. Papa, P.P. Pandolfi Regulation of apoptosis by PML and the PML-NBs Oncogene 27 2008 6299 6312
19. E.L. Reineke, H.Y. Kao Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies Int J Biol Sci 5 2009 366 376
20. M.H. Koken, F. Puvion-Dutilleul, M.C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, H. de Th The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion EMBO J 13 1994 1073 1083
21. H. de Th, C. Lavau, A. Marchio, C. Chomienne, L. Degos, A. Dejean The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR Cell 66 1991 675 684
22. A.D. Goddard, J. Borrow, P.S. Freemont, E. Solomon Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia Science 254 1991 1371 1374
23. A. Kakizuka, W.H. Miller Jr, K. Umesono, R.P. Warrell Jr, S.R. Frankel, V.V. Murty, E. Dmitrovsky, R.M. Evans Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML Cell 66 1991 663 674
24. C. Gurrieri, P. Capodieci, R. Bernardi, P.P. Scaglioni, K. Nafa, L.J. Rush, D.A. Verbel, C. Cordon-Cardo, P.P. Pandolfi Loss of the tumor suppressor PML in human cancers of multiple histologic origins J Natl Cancer Inst 96 2004 269 279
25. J. Takahashi, H. Fujigasaki, K. Iwabuchi, A.C. Bruni, T. Uchihara, K.H. El Hachimi, G. Stevanin, A. Drr, A.S. Lebre, Y. Trottier, H. de Th, J. Tanaka, J.J. Hauw, C. Duyckaerts, A. Brice PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases Neurobiol Dis 13 2003 230 237
26. J. Takahashi, H. Fujigasaki, C. Zander, K.H. El Hachimi, G. Stevanin, A. Drr, A.S. Lebre, G. Yvert, Y. Trottier, H. de Th, J.J. Hauw, C. Duyckaerts, A. Brice Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content Brain 125 2002 1534 1543
27. M. Yamada, T. Sato, T. Shim Hata, S. Hayashi, S. Igarashi, S. Tsuji, H. Takahashi Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases Am J Pathol 159 2001 1785 1795
28. N. Tubalia, T. Stemming New insights into the role of the subnuclear structure ND10 for viral infection Biochim Biophys Acta 1783 2008 2207 2221
29. R.D. Everett, M.K. Chelbi-Alix PML and PML nuclear bodies: implications in antiviral defence Biochimie 89 2007 819 830
30. R.D. Everett DNA viruses and viral proteins that interact with PML nuclear bodies Oncogene 20 2001 7266 7273
31. M. Jiang, P. Entezami, M. Gamez, T. Stemming, M.J. Imperiale Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection MBio 2 2011 e0028110
32. Y. Takebe, M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, N. Arai SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat Mol Cell Biol 8 1988 466 472
33. L. Schermelleh, P.M. Carlton, S. Haase, L. Shao, L. Winoto, P. Kner, B. Burke, M.C. Cardoso, D.A. Agard, M.G. Gustafsson, H. Leonhardt, J.W. Sedat Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy Science 320 2008 1332 1336
34. Y. Shishido, S. Nukuzuma, J. Mukaigawa, S. Morikawa, K. Yasui, K. Nagashima Assembly of JC virus-like particles in COS7 cells J Med Virol 51 1997 265 272
35. R.J. Frisque, G.L. Bream, M.T. Cannella Human polyomavirus JC virus genome J Virol 51 1984 458 469
36. A.M. Daniel, R.J. Frisque Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs Virology 194 1993 97 109
37. E.O. Major, A.E. Miller, P. Mourrain, R.G. Traub, E. de Widt, J. Sever Establishment of a line of human fetal glial cells that supports JC virus multiplication Proc Natl Acad Sci USA 82 1985 1257 1261
38. C. Mandl, D.L. Walker, R.J. Frisque Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus J Virol 61 1987 755 763
39. S. Radhakrishnan, J. Otte, S. Enam, L. Del Valle, K. Khalili, J. Gordon JC virus-induced changes in cellular gene expression in primary human astrocytes J Virol 77 2003 10638 10644
40. I.K. Sariyer, M. Safak, J. Gordon, K. Khalili Generation and characterization of JCV permissive hybrid cell lines J Virol Methods 159 2009 122 126
41. K. Hara, C. Sugimoto, T. Kitamura, N. Aoki, F. Taguchi, Y. Yogo Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen J Virol 72 1998 5335 5342
42. R. Gosert, C.H. Rinaldo, M. Wernli, E.O. Major, H.H. Hirsch CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes Antimicrob Agents Chemother 55 2011 2129 2136
43. I. Akan, I.K. Sariyer, R. Biffi, V. Palermo, S. Woolridge, M.K. White, S. Amini, K. Khalili, M. Safak Human polyomavirus JCV late leader peptide region contains important regulatory elements Virology 349 2006 66 78
44. M. Safak, B. Sadowska, R. Barrucco, K. Khalili Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1 J Virol 76 2002 3828 3838
45. T. Suzuki, Y. Orba, Y. Okada, Y. Sunden, T. Kimura, S. Tanaka, K. Nagashima, W.W. Hall, H. Sawa The human polyoma JC virus agnoprotein acts as a viroporin PLoS Pathog 6 2010 e1000801
46. A. Darbinyan, K.M. Siddiqui, D. Slonina, N. Darbinian, S. Amini, M.K. White, K. Khalili Role of JC virus agnoprotein in DNA repair J Virol 78 2004 8593 8600
47. K. Khalili, M.K. White, H. Sawa, K. Nagashima, M. Safak The agnoprotein of polyomaviruses: a multifunctional auxiliary protein J Cell Physiol 204 2005 1 7
48. A. Darbinyan, N. Darbinian, M. Safak, S. Radhakrishnan, A. Giordano, K. Khalili Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein Oncogene 21 2002 5574 5581
49. N. Merabova, D. Kaniowska, R. Kaminski, S.L. Deshmane, M.K. White, S. Amini, A. Darbinyan, K. Khalili JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis J Virol 82 2008 1558 1569
50. I.K. Sariyer, A.S. Saribas, M.K. White, M. Safak Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content Virol J 8 2011 255
51. M.R. Myhre, G.H. Olsen, R. Gosert, H.H. Hirsch, C.H. Rinaldo Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation Virology 398 2010 12 20
52. M.L. Gasparovic, M.S. Maginnis, B.A. O'Hara, A.S. Dugan, W.J. Atwood Modulation of PML protein expression regulates JCV infection Virology 390 2009 279 288
53. X. Dang, J.E. Vidal, A.C. Penalva de Oliveira, D.M. Simpson, S. Morgello, J.H. Hecht, L.H. Ngo, I.J. Koralnik JC virus granule cell neuronopathy is associated with VP1 C terminus mutants J Gen Virol 93 2012 175 183
54. C.S. Tan, I.J. Koralnik Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis Lancet Neurol 9 2010 425 437
55. I.J. Koralnik, C. Wthrich, X. Dang, M. Rottnek, A. Gurtman, D. Simpson, S. Morgello JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy Ann Neurol 57 2005 576 580
56. C. Wthrich, X. Dang, S. Westmoreland, J. McKay, A. Maheshwari, M.P. Anderson, A.H. Ropper, R.P. Viscidi, I.J. Koralnik Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons Ann Neurol 65 2009 742 748
57. C. Wthrich, Y.M. Cheng, J.T. Joseph, S. Kesari, C. Beckwith, E. Stopa, J.E. Bell, I.J. Koralnik Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy J Neuropathol Exp Neurol 68 2009 15 25